Venture
Showing 91–120 of 156 results
-
Venture
Intron Bio
Intron Bio is a biotechnology company that has been involved in various activities. They have been developing diagnostic kits for infectious diseases and have also been involved in activities related to beekeeping. They have a product called LiliF, a diagnostic kit that can simultaneously test for 8 major infectious diseases. They also have a division called DR Part, which seems to be involved in marketing and customer service.
-
Venture
Inventage Lab
Inventage Lab is a research company established in 2017 that focuses on the development of gene therapies using RNA. They have a focus on drug toxicity evaluation platforms using stem cell-derived functional cells.
-
Venture
IPS Bio
iPSBIO Aim To Provide Fundamental Solutions to Treat Intractable Neurological Diseases Using Innovative iPSC-Based Cell & Gene Therapy and Drug Discovery Approaches
-
Venture
JD Bioscience
JD Bioscience is a company that develops new small molecule therapeutics for metabolic diseases, including obesity and fatty liver disease. They aim to help people live longer and healthier lives by discovering novel therapeutics for metabolic diseases with unmet medical needs.
-
Venture
K-Cell Co., Ltd.
-
Venture
Kanzen Biotechnology
-
Venture
Lab Genomics
Lab Genomics is a healthcare company specializing in molecular diagnostics. They have developed a range of products including the STDetect® Chip, MyPCR™, MyGelDoc™, LabGun™ Dengue, LabGun™ Malaria, and LabGun™ mTB. They are committed to developing new and effective diagnostic methods.
-
Venture
Liveome
Liveome is a company that focuses on the development of microbiome-based microbial therapeutics. They aim to overcome incurable diseases with next-generation microbiome technology.
-
Venture
Medigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
Venture
NeuroVenti
NeuroVenti is a company that focuses on the development of neuroprotective and therapeutic agents against neuronal disorders. They have successfully obtained FDA orphan drug designation for their autism treatment candidate (NV01-A02) and are currently preparing for phase 2 clinical trials in Korea.
-
Venture
Nexell
Nexell is a company that focuses on iPSC (induced pluripotent stem cell) technology. They offer iPSC technology such as Cardiomyocytes, Hepatosight, Neurosight, Cardiac Safety Service, and hERG Assay.
-
Venture
NKMAX
Specialized biological research reagents for the biotech and health industries
NKMAX’s proteins and antibodies development has stemmed from its stable-peptide (SP) fusion technology, which was originally designed to stabilize proteins susceptible to damage from its environment.
NKMAX manufactures more than 5,000 different recombinant proteins and over 400 monoclonal antibodies being sold in over 38 countries around the world. -
Venture
Novarex
-
Venture
nSAGE
-
Venture
OliPass
Since 2006, OliPass has been committed to revolutionizing the life sciences and improving the quality of life. Our research is focused on developing a new generation of therapeutics using our novel PNA based technologies. Thanks to our dedicated team and their hard work, OliPass is now a leading biotech company with OliPass PNA Platform Technology and a growing presence throughout the globe.
At OliPass, scientists from diverse fields are constantly working together to find the cures for all diseases. With our innovative OliPass PNA platform technology, our goal is to make the highest quality of science affordable and accessible, so that everyone around the world can enjoy a happy, healthy life. OliPass is dedicated to providing safe and feasible options for healthy aging. -
Venture
OliX Pharmaceuticals
OliX Pharmaceuticals is a clinical stage pharmaceutical company developing therapeutics against a variety of disorders based on its proprietary RNAi technology.
-
Venture
PAEAN Biotechnology
PAEAN Biotechnology strives to develop revolutionary first-in-class medicinal products through a proprietary platform based on the unique characteristics of mitochondria.
-
Venture
Panagene